MPM BioImpact’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-855,437	Closed	-$6.56M	–	12
2020 Q1	$6.56M	Hold	855,437	–	–	4.01%	8
2019 Q4	$7.11M	Buy	+855,437	New	+$7.11M	2.52%	10